LifeSouth seeks plasma donations from recovered COVID-19 patients to treat critical patients

Press release from LifeSouth

Plasma will be used in an investigational new drug to help treat critically ill COVID-19 patients

LifeSouth is partnering with medical centers in Florida, Georgia and Alabama to collect plasma from COVID-19 patients who have recovered from the virus, to transfuse to patients with COVID-19 to help with recovery.

Recovered COVID-19 patients who were tested and found positive, can donate plasma if they have not had symptoms for at least 14 days and test negative by a lab, or after 28 days without symptoms with no follow-up testing required.  

The treatment is considered an investigational new drug by the FDA and collected donations will be sent to medical centers to treat critically ill COVID-19 patients. The plasma contains antibodies that may help fight the virus.

Plasma is the clear, straw-colored liquid in the blood that remains when red blood cells, white blood cells and platelets are removed.  

Potential donors should email or call 888-795-2707.  

Be the first to comment

Leave a Reply